http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004513928-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 |
filingDate | 2001-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2004-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2004513928-A |
titleOfInvention | Inhalation of nitric oxide |
abstract | To prevent subordinate or non-response to treatment with gaseous nitric oxide or nitric oxide donor alone and / or to prevent recoil response in the case of discontinuation of treatment with gaseous nitric oxide or nitric oxide donor alone The use of inhalable gaseous nitric oxide (NO) in combination with a cyclooxygenase inhibitor for the manufacture of a medicament for treating pulmonary vasoconstriction or airway constriction in mammals, including humans, to inhibit. Thus, the combination is used in a therapeutically effective amount to achieve relaxation of the pulmonary vasoconstriction or airway constriction. Methods and pharmaceutical preparations for the treatment of pulmonary vasoconstriction or airway constriction using the above combinations. |
priorityDate | 2000-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 147.